Intrathecal rituximab treatment for pediatric post-transplan…
Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
Article, Chapter
Full text availability for this item
Coverage:
- 2004~present; volume:42~present;issue:1~present
Coverage:
- 2004-01-01~present; volume:42~present;issue:1~present